{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:03:40Z","timestamp":1786737820650,"version":"build-2736575974"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/1673-5374.320971","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T02:44:04Z","timestamp":1629427444000},"page":"503","source":"Crossref","is-referenced-by-count":30,"title":["Promise of metformin for preventing age-related cognitive dysfunction"],"prefix":"10.4103","volume":"17","author":[{"given":"AshokK","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeelavathiN","family":"Madhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheedhar","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.320971-1","doi-asserted-by":"crossref","unstructured":"Adak T, Samadi A, \u00dcnal AZ, Sabuncuo\u011flu S (2018) A reappraisal on metformin. Regul Toxicol Pharmacol 92:324-332.","DOI":"10.1016\/j.yrtph.2017.12.023"},{"key":"key-10.4103\/1673-5374.320971-2","doi-asserted-by":"crossref","unstructured":"Ahmadi S, Razazan A, Nagpal R, Jain S, Wang B, Mishra, SP, Wang S, Justice J, Ding J, McClain DA, Kritchevsky SB, Kitzman D, Yadav H (2020) Metformin reduces aging-related leaky gut and improves cognitive function by beneficially modulating gut microbiome\/goblet cell\/mucin axis. J Gerontol A Biol Sci Med Sci 75:e9-21.","DOI":"10.1093\/gerona\/glaa056"},{"key":"key-10.4103\/1673-5374.320971-3","doi-asserted-by":"crossref","unstructured":"Ai H, Fang W, Hu H, Hu X, Lu W (2020) Antidiabetic drug metformin ameliorates depressive-like behavior in mice with chronic restraint stress via activation of AMP-activated protein kinase. Aging Dis 11:31-43.","DOI":"10.14336\/AD.2019.0403"},{"key":"key-10.4103\/1673-5374.320971-4","doi-asserted-by":"crossref","unstructured":"Allard JS, Perez EJ, Fukui K, Carpenter P, Ingram DK, de Cabo R (2016) Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL\/6J mice. Behav Brain Res 301:1-9.","DOI":"10.1016\/j.bbr.2015.12.012"},{"key":"key-10.4103\/1673-5374.320971-5","doi-asserted-by":"crossref","unstructured":"Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP (2016) Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab 101:1754-1761.","DOI":"10.1210\/jc.2015-3754"},{"key":"key-10.4103\/1673-5374.320971-6","doi-asserted-by":"crossref","unstructured":"Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA (2016) Metformin as a tool to target aging. Cell Metab 23:1060-1065.","DOI":"10.1016\/j.cmet.2016.05.011"},{"key":"key-10.4103\/1673-5374.320971-7","doi-asserted-by":"crossref","unstructured":"Bockaert J, Marin P (2015) mTOR in brain physiology and pathologies. Physiol Rev 95:1157-1187.","DOI":"10.1152\/physrev.00038.2014"},{"key":"key-10.4103\/1673-5374.320971-8","doi-asserted-by":"crossref","unstructured":"Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK, Viollet B, Sakamoto K, Fagerholm SC, Foretz M, Lang CC, Rena G (2016) Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res 119:652-665.","DOI":"10.1161\/CIRCRESAHA.116.308445"},{"key":"key-10.4103\/1673-5374.320971-9","doi-asserted-by":"crossref","unstructured":"Chaudhari K, Reynolds CD, Yang SH (2020) Metformin and cognition from the perspectives of sex, age, and disease. Geroscience 42:97-116.","DOI":"10.1007\/s11357-019-00146-3"},{"key":"key-10.4103\/1673-5374.320971-10","doi-asserted-by":"crossref","unstructured":"Chen F, Dong RR, Zhong KL, Ghosh A, Tang SS, Long Y, Hu M, Miao MX, Liao JM, Sun HB, Kong LY, Hong H (2016) Antidiabetic drugs restore abnormal transport of amyloid-\u03b2 across the blood-brain barrier and memory impairment in db\/db mice. Neuropharmacology 101:23-136.","DOI":"10.1016\/j.neuropharm.2015.07.023"},{"key":"key-10.4103\/1673-5374.320971-11","doi-asserted-by":"crossref","unstructured":"Cheng C, Lin CH, Tsai YW, Tsai CJ, Chou PH, Lan TH (2014) Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. J Gerontol A Biol Sci Med Sci 69:1299-1305.","DOI":"10.1093\/gerona\/glu073"},{"key":"key-10.4103\/1673-5374.320971-12","doi-asserted-by":"crossref","unstructured":"Dazert E, Hall MN (2011) mTOR signaling in disease. Curr Opin Cell Biol 23:744-755.","DOI":"10.1016\/j.ceb.2011.09.003"},{"key":"key-10.4103\/1673-5374.320971-13","doi-asserted-by":"crossref","unstructured":"de Magalh\u00e3es JP, Stevens M, Thornton D (2017) The business of anti-aging science. Trends Biotechnol 35:1062-1073.","DOI":"10.1016\/j.tibtech.2017.07.004"},{"key":"key-10.4103\/1673-5374.320971-14","doi-asserted-by":"crossref","unstructured":"Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, Fimia GM, Fulda S, Gewirtz DA, Green DR, Hansen M, et al. (2017) Molecular definitions of autophagy and related processes. EMBO J 36:1811-1836.","DOI":"10.15252\/embj.201796697"},{"key":"key-10.4103\/1673-5374.320971-15","doi-asserted-by":"crossref","unstructured":"Glatigny M, Moriceau S, Rivagorda M, Ramos-Brossier M, Nascimbeni AC, Lante F, Shanley MR, Boudarene N, Rousseaud A, Friedman AK, Settembre C, Kuperwasser N, Friedlander G, Buisson A, Morel E, Codogno P, Oury F (2019) Autophagy is required for memory formation and reverses age-related memory decline. Curr Biol 29:435-448.","DOI":"10.1016\/j.cub.2018.12.021"},{"key":"key-10.4103\/1673-5374.320971-16","doi-asserted-by":"crossref","unstructured":"Guo M, Mi J, Jiang QM, Xu JM, Tang YY, Tian G, Wang B (2014) Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharmacol Physiol 41:650-656.","DOI":"10.1111\/1440-1681.12265"},{"key":"key-10.4103\/1673-5374.320971-17","doi-asserted-by":"crossref","unstructured":"Gur\u0103u F, Baldoni S, Prattichizzo F, Espinosa E, Amenta F, Procopio AD, Albertini MC, Bonafe M, Olivieri F (2018) Anti-senescence compounds: a potential nutraceutical approach to healthy aging. Ageing Res Rev 46:14-31.","DOI":"10.1016\/j.arr.2018.05.001"},{"key":"key-10.4103\/1673-5374.320971-18","doi-asserted-by":"crossref","unstructured":"Harada CN, Natelson Love MC, Triebel KL (2013) Normal cognitive aging. Clin Geriatr Med 29: 737-752.","DOI":"10.1016\/j.cger.2013.07.002"},{"key":"key-10.4103\/1673-5374.320971-19","doi-asserted-by":"crossref","unstructured":"Hawley SA, Gadalla AE, Olsen GS, Hardie DG (2002) The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420-2425.","DOI":"10.2337\/diabetes.51.8.2420"},{"key":"key-10.4103\/1673-5374.320971-20","doi-asserted-by":"crossref","unstructured":"Hsu CC, Wahlqvist ML, Lee MS, Tsai HN (2011) Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 24:485-493.","DOI":"10.3233\/JAD-2011-101524"},{"key":"key-10.4103\/1673-5374.320971-21","doi-asserted-by":"crossref","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR (2012) Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study. J Am Geriatr Soc 60:916-921.","DOI":"10.1111\/j.1532-5415.2012.03916.x"},{"key":"key-10.4103\/1673-5374.320971-22","doi-asserted-by":"crossref","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Br\u00fbl\u00e9 S, Viollet B, Kemp BE, Bardeesy N, Dennis P, Schlager JJ, Marette A, Kozma SC, Thomas G (2010) Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 11:390-401.","DOI":"10.1016\/j.cmet.2010.03.014"},{"key":"key-10.4103\/1673-5374.320971-23","doi-asserted-by":"crossref","unstructured":"Kobilo T, Guerrieri D, Zhang Y, Collica SC, Becker KG, van Praag H (2014) AMPK agonist AICAR improves cognition and motor coordination in young and aged mice. Learn Mem 21:119-126.","DOI":"10.1101\/lm.033332.113"},{"key":"key-10.4103\/1673-5374.320971-24","doi-asserted-by":"crossref","unstructured":"Kodali M, Attaluri S, Madhu LN, Shuai B, Upadhya R, Gonzalez JJ, Rao X, Shetty AK (2021) Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus. Aging Cell 20:e13277.","DOI":"10.1111\/acel.13277"},{"key":"key-10.4103\/1673-5374.320971-25","doi-asserted-by":"crossref","unstructured":"Kodali M, Parihar VK, Hattiangady B, Mishra V, Shuai B, Shetty AK (2015) Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci Rep 5:8075.","DOI":"10.1038\/srep08075"},{"key":"key-10.4103\/1673-5374.320971-26","doi-asserted-by":"crossref","unstructured":"Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE (2017) Effects of the insulin sensitizer metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis Assoc Disord 31:107-113.","DOI":"10.1097\/WAD.0000000000000202"},{"key":"key-10.4103\/1673-5374.320971-27","doi-asserted-by":"crossref","unstructured":"Kulkarni AS, Gubbi S, Barzilai N (2020) Benefits of metformin in attenuating the hallmarks of aging. Cell Metab 32:15-30.","DOI":"10.1016\/j.cmet.2020.04.001"},{"key":"key-10.4103\/1673-5374.320971-28","doi-asserted-by":"crossref","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274-293.","DOI":"10.1016\/j.cell.2012.03.017"},{"key":"key-10.4103\/1673-5374.320971-29","doi-asserted-by":"crossref","unstructured":"Lennox R, Porter DW, Flatt PR, Holscher C, Irwin N, Gault VA (2014) Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice. Neuropharmacology 86:22-30.","DOI":"10.1016\/j.neuropharm.2014.06.026"},{"key":"key-10.4103\/1673-5374.320971-30","doi-asserted-by":"crossref","unstructured":"Li J, Deng J, Sheng W, Zuo Z (2012) Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 101:564-574.","DOI":"10.1016\/j.pbb.2012.03.002"},{"key":"key-10.4103\/1673-5374.320971-31","doi-asserted-by":"crossref","unstructured":"Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672-676.","DOI":"10.1038\/45257"},{"key":"key-10.4103\/1673-5374.320971-32","doi-asserted-by":"crossref","unstructured":"Ma YR, Qin HY, Jin YW, Huang J, Han M, Wang XD, Zhang GQ, Zhou Y, Rao Z, Wu XA (2016) Gender-related differences in the expression of organic cation transporter 2 and its role in urinary excretion of metformin in rats. Eur J Drug Metab Pharmacokinet 41:559-565.","DOI":"10.1007\/s13318-015-0278-1"},{"key":"key-10.4103\/1673-5374.320971-33","doi-asserted-by":"crossref","unstructured":"McNeilly AD, Williamson R, Balfour DJ, Stewart CA, Sutherland C (2012) A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia 55:3061-3070.","DOI":"10.1007\/s00125-012-2686-y"},{"key":"key-10.4103\/1673-5374.320971-34","doi-asserted-by":"crossref","unstructured":"Meares GP, Qin H, Liu Y, Holdbrooks AT, Benveniste EN (2013) AMP-activated protein kinase restricts IFN-\u03b3 signaling. J Immunol 190:372-380.","DOI":"10.4049\/jimmunol.1202390"},{"key":"key-10.4103\/1673-5374.320971-35","doi-asserted-by":"crossref","unstructured":"Miquel S, Champ C, Day J, Aarts E, Bahr BA, Bakker M, B\u00e1n\u00e1ti D, Calabrese V, Cederholm T, Cryan J, Dye L, Farrimond JA, Korosi A, Lay\u00e9 S, Maudsley S, Milenkovic D, Mohajeri MH, Sijben J, Solomon A, Spencer JPE, et al. (2018) Poor cognitive ageing: vulnerabilities, mechanisms and the impact of nutritional interventions. Ageing Res Rev 42:40-55.","DOI":"10.1016\/j.arr.2017.12.004"},{"key":"key-10.4103\/1673-5374.320971-36","doi-asserted-by":"crossref","unstructured":"Moiseeva O, Desch\u00eanes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN, Ferbeyre G (2013) Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-\u03baB activation. Aging cell 12:489-498.","DOI":"10.1111\/acel.12075"},{"key":"key-10.4103\/1673-5374.320971-37","doi-asserted-by":"crossref","unstructured":"Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux ng, Martins R, Szoeke C, Rowe C, Watters DA (2013) Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 36:2981-2987.","DOI":"10.2337\/dc13-0229"},{"key":"key-10.4103\/1673-5374.320971-38","doi-asserted-by":"crossref","unstructured":"Mostafa DK, Ismail CA, Ghareeb DA (2016) Differential metformin dose-dependent effects on cognition in rats: role of Akt. Psychopharmacology (Berl) 233:2513-2524.","DOI":"10.1007\/s00213-016-4301-2"},{"key":"key-10.4103\/1673-5374.320971-39","doi-asserted-by":"crossref","unstructured":"Myeku N, Figueiredo-Pereira ME (2011) Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1\/p62. J Biol Chem 286:22426-22440.","DOI":"10.1074\/jbc.M110.149252"},{"key":"key-10.4103\/1673-5374.320971-40","doi-asserted-by":"crossref","unstructured":"Nair V, Pathi S, Jutooru I, Sreevalsan S, Basha R, Abdelrahim M, Samudio I, Safe S (2013) Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Carcinogenesis 34:2870-2879.","DOI":"10.1093\/carcin\/bgt231"},{"key":"key-10.4103\/1673-5374.320971-41","doi-asserted-by":"crossref","unstructured":"Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B (2014) Long-term metformin usage and cognitive function among older adults with diabetes. J Alzheimers Dis 41:61-68.","DOI":"10.3233\/JAD-131901"},{"key":"key-10.4103\/1673-5374.320971-42","doi-asserted-by":"crossref","unstructured":"Okerlund ND, Schneider K, Leal-Ortiz S, Montenegro-Venegas C, Kim SA, Garner LC, Waites CL, Gundelfinger ED, Reimer RJ, Garner CC (2017) Bassoon controls presynaptic autophagy through Atg5. Neuron 93:897-913.","DOI":"10.1016\/j.neuron.2017.01.026"},{"key":"key-10.4103\/1673-5374.320971-43","doi-asserted-by":"crossref","unstructured":"Orkaby AR, Cho K, Cormack J, Gagnon DR, Driver JA (2017) Metformin vs sulfonylurea use and risk of dementia in US veterans aged \u2265 65 years with diabetes. Neurology 89:1877-1885.","DOI":"10.1212\/WNL.0000000000004586"},{"key":"key-10.4103\/1673-5374.320971-44","doi-asserted-by":"crossref","unstructured":"Pintana H, Apaijai N, Pratchayasakul W, Chattipakorn N, Chattipakorn S (2012) Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sci 91:409-414.","DOI":"10.1016\/j.lfs.2012.08.017"},{"key":"key-10.4103\/1673-5374.320971-45","doi-asserted-by":"crossref","unstructured":"Rotermund C, Machetanz G, Fitzgerald JC (2018) The therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol (Lausanne) 9:400.","DOI":"10.3389\/fendo.2018.00400"},{"key":"key-10.4103\/1673-5374.320971-46","doi-asserted-by":"crossref","unstructured":"Rowe JW, Kahn RL (1997) Successful aging. Gerontologist 37:433-440.","DOI":"10.1093\/geront\/37.4.433"},{"key":"key-10.4103\/1673-5374.320971-47","doi-asserted-by":"crossref","unstructured":"Ruddy RM, Adams KV, Morshead CM (2019) Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke. Sci Adv 5:eaax1912.","DOI":"10.1126\/sciadv.aax1912"},{"key":"key-10.4103\/1673-5374.320971-48","doi-asserted-by":"crossref","unstructured":"Samaras K, Makkar S, Crawford JD, Kochan NA, Wen W, Draper B, Trollor JN, Brodaty H, Sachdev PS (2020) Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the Sydney memory and ageing study. Diabetes Care 43:2691-2701.","DOI":"10.2337\/dc20-0892"},{"key":"key-10.4103\/1673-5374.320971-49","doi-asserted-by":"crossref","unstructured":"Scrivo A, Bourdenx M, Pampliega O, Cuervo AM (2018) Selective autophagy as a potential therapeutic target for neurodegenerative disorders. Lancet Neurol 17:802-815.","DOI":"10.1016\/S1474-4422(18)30238-2"},{"key":"key-10.4103\/1673-5374.320971-50","doi-asserted-by":"crossref","unstructured":"Sengoku R (2020) Aging and Alzheimer\u2019s disease pathology. Neuropathology 40:22-29.","DOI":"10.1111\/neup.12626"},{"key":"key-10.4103\/1673-5374.320971-51","doi-asserted-by":"crossref","unstructured":"Shetty AK, Hattiangady B, Shetty GA (2005) Stem\/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia 51:173-186.","DOI":"10.1002\/glia.20187"},{"key":"key-10.4103\/1673-5374.320971-52","doi-asserted-by":"crossref","unstructured":"Shetty AK, Kodali M., Upadhya R, Madhu LN (2018) Emerging anti-aging strategies - scientific basis and efficacy. Aging Dis 9:1165-1184.","DOI":"10.14336\/AD.2018.1026"},{"key":"key-10.4103\/1673-5374.320971-53","doi-asserted-by":"crossref","unstructured":"Shetty AK, Upadhya R, Madhu LN, Kodali M (2019) Novel insights on systemic and brain aging, stroke, amyotrophic lateral sclerosis, and Alzheimer\u2019s disease. Aging Dis 10:470-482.","DOI":"10.14336\/AD.2019.0330"},{"key":"key-10.4103\/1673-5374.320971-54","doi-asserted-by":"crossref","unstructured":"Slomovitz BM, Coleman RL (2012) The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res 18:5856-5864.","DOI":"10.1158\/1078-0432.CCR-12-0662"},{"key":"key-10.4103\/1673-5374.320971-55","doi-asserted-by":"crossref","unstructured":"Stambler I (2017) Recognizing degenerative aging as a treatable medical condition: methodology and policy. Aging Dis 8:583-589.","DOI":"10.14336\/AD.2017.0130"},{"key":"key-10.4103\/1673-5374.320971-56","doi-asserted-by":"crossref","unstructured":"Stephenne X, Foretz M, Taleux N, van der Zon GC, Sokal E, Hue L, Viollet B, Guigas B (2011) Metformin activates AMP activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia 54:3101-3110.","DOI":"10.1007\/s00125-011-2311-5"},{"key":"key-10.4103\/1673-5374.320971-57","doi-asserted-by":"crossref","unstructured":"Stern Y (2012) Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol 11:1006-1012.","DOI":"10.1016\/S1474-4422(12)70191-6"},{"key":"key-10.4103\/1673-5374.320971-58","doi-asserted-by":"crossref","unstructured":"Thangthaeng N, Rutledge M, Wong JM, Vann PH, Forster MJ, Sumien N (2017) Metformin impairs spatial memory and visual acuity in old male mice. Aging Dis 8:17-30.","DOI":"10.14336\/AD.2016.1010"},{"key":"key-10.4103\/1673-5374.320971-59","doi-asserted-by":"crossref","unstructured":"Van Skike CE, Jahrling JB, Olson AB, Sayre NL, Hussong SA, Ungvari Z, Lechleiter JD, Galvan V (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer\u2019s disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-703.","DOI":"10.1152\/ajpheart.00570.2017"},{"key":"key-10.4103\/1673-5374.320971-60","doi-asserted-by":"crossref","unstructured":"Verdile G, Fuller SJ, Martins RN (2015) The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 84:22-38.","DOI":"10.1016\/j.nbd.2015.04.008"},{"key":"key-10.4103\/1673-5374.320971-61","doi-asserted-by":"crossref","unstructured":"Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 285:9100-9113.","DOI":"10.1074\/jbc.M109.060061"},{"key":"key-10.4103\/1673-5374.320971-62","doi-asserted-by":"crossref","unstructured":"Wang CP, Lorenzo C, Habib SL, Jo B, Espinoza SE (2017) Differential effects of metformin on age related comorbidities in older men with type 2 diabetes. J Diabetes Complications 31:679-686.","DOI":"10.1016\/j.jdiacomp.2017.01.013"},{"key":"key-10.4103\/1673-5374.320971-63","doi-asserted-by":"crossref","unstructured":"Xiong LL, Chen J, Du RL, Liu J, Chen YJ, Hawwas M, Zhou XF, Wang TH, Yang SJ, Bai X (2021) Brain-derived neurotrophic factor and its related enzymes and receptors play important roles after hypoxic-ischemic brain damage. Neural Reg Res 16:1453-1459.","DOI":"10.4103\/1673-5374.303033"},{"key":"key-10.4103\/1673-5374.320971-64","doi-asserted-by":"crossref","unstructured":"Xu XJ, Gauthier MS, Hess DT, Apovian CM, Cacicedo JM, Gokce N, Farb M, Valentine RJ, Ruderman NB (2012) Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res 53:792-801.","DOI":"10.1194\/jlr.P022905"},{"key":"key-10.4103\/1673-5374.320971-65","doi-asserted-by":"crossref","unstructured":"Yokoyama H, Ogawa M, Honjo J, Okizaki S, Yamada D, Shudo R, Shimizu H, Haneda M (2015) Risk factors associated with abnormal cognition in Japanese outpatients with diabetes, hypertension or dyslipidemia. Diabetol Int 6:268-274.","DOI":"10.1007\/s13340-014-0194-7"},{"key":"key-10.4103\/1673-5374.320971-66","doi-asserted-by":"crossref","unstructured":"Zhao M, Cheng X, Lin X, Han Y, Zhou Y, Zhao T He Y, Wu L, Zhao Y, Fan M, Zhu L (2019) Metformin administration prevents memory impairment induced by hypobaric hypoxia in rats. Behav Brain Res 363:30-37.","DOI":"10.1016\/j.bbr.2019.01.048"},{"key":"key-10.4103\/1673-5374.320971-67","doi-asserted-by":"crossref","unstructured":"Zhou W, Kavelaars A, Heijnen CJ (2016) Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS One 11:e0151890.","DOI":"10.1371\/journal.pone.0151890"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:00:03Z","timestamp":1786734003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.320971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["320971"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.320971","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}